advisory panels

FDA advisers divided on Sanofi’s oral type 1 diabetes drug
FDA advisers divided on Sanofi’s oral type 1 diabetes drug
Pharmaforum
Sanofi
Lexicon Pharmaceuticals
type 1 diabetes
Zynquista
FDA
advisory panels
sotagliflozin
Flag link:
Amgen's once-dismissed osteoporosis drug Evenity 'back in the game' after rosy FDA panel vote
Amgen's once-dismissed osteoporosis drug Evenity 'back in the game' after rosy FDA panel vote
Fierce Pharma
Amgen
osteoporosis
Evenity
romosozumab
FDA
advisory panels
Flag link:
Naloxone Availability: FDA Meeting Next Week
Naloxone Availability: FDA Meeting Next Week
RAPS.org
FDA
advisory panels
opioids
opioid crisis
opioid overdose
Naloxone
Flag link:
FDA advisory panel to mull transvaginal mesh
FDA advisory panel to mull transvaginal mesh
Mass Device
FDA
devices
transvaginal mesh
advisory panels
Flag link:
With FDA Panel’s Nod, First Postpartum Depression Drug Nears Approval
With FDA Panel’s Nod, First Postpartum Depression Drug Nears Approval
Xconomy
FDA
advisory panels
SAGE Therapeutics
postpartum depression
brexanolone
Flag link:
Alkermes Depression Drug Faces Long Odds After FDA Advisors Say No
Alkermes Depression Drug Faces Long Odds After FDA Advisors Say No
Xconomy
Alkermes
FDA
advisory panels
ALKS-5461
major depressive disorder
Flag link:
FDA advisers back Shire constipation drug
FDA advisers back Shire constipation drug
Pharmaforum
FDA
Shire
advisory panels
prucalopride
CIC
chronic idiopathic constipation
Flag link:
Advisory panel narrowly rejects oliceridine for acute pain
Advisory panel narrowly rejects oliceridine for acute pain
BioCentury
FDA
advisory panels
Trevena
TRV130
severe pain
Flag link:
FDA panel unanimously backs Celltrion's Rituxan biosimilar
FDA panel unanimously backs Celltrion's Rituxan biosimilar
Fierce Pharma
Celltrion
Teva Pharmaceutical
biosimilars
Rituxan
FDA
advisory panels
Flag link:
Trevena shares sink on FDA concerns ahead of key panel meeting
Trevena shares sink on FDA concerns ahead of key panel meeting
Biopharma Dive
Trevena
FDA
advisory panels
oliceridine
opioids
Flag link:
FDA reviewers endorse Celltrion's Rituxan biosimilar ahead of panel vote
FDA reviewers endorse Celltrion's Rituxan biosimilar ahead of panel vote
Fierce Pharma
Celltrion
Roche
biosimilars
Rituxan
FDA
advisory panels
Flag link:
Paratek clears one last big hurdle on the way to an FDA marketing decision for antibiotic
Paratek clears one last big hurdle on the way to an FDA marketing decision for antibiotic
Endpoints
Paratek
antibiotics
omadacycline
FDA
advisory panels
Flag link:
FDA advisory panel turns down PneumRx’s Elevair lung implant
FDA advisory panel turns down PneumRx’s Elevair lung implant
Fierce Biotech
FDA
advisory panels
PneumRx
Elevair
lung implants
emphysema
Flag link:
Rejected: After paying $80M to acquire it, Mallinckrodt’s jaundice drug snubbed by FDA’s advisory committee
Rejected: After paying $80M to acquire it, Mallinckrodt’s jaundice drug snubbed by FDA’s advisory committee
Endpoints
Mallinckrodt
FDA
advisory panels
infantile jaundice
InfaCare
stannsoporfin
Flag link:
FDA Panel Splits on Lilly Arthritis Drug, Backs Lower of Two Doses
FDA Panel Splits on Lilly Arthritis Drug, Backs Lower of Two Doses
Xconomy
Eli Lilly
FDA
advisory panels
rheumatoid arthritis
baricitinib
Incyte
Flag link:
FDA Panel Votes To Approve Marijuana-Based Drug For Epilepsy
FDA Panel Votes To Approve Marijuana-Based Drug For Epilepsy
Forbes
FDA
GW Pharma
Epidiolex
epilepsy
advisory panels
Flag link:
Pfizer Gets FDA Panel Backing for New Indication for Xeljanz
Pfizer Gets FDA Panel Backing for New Indication for Xeljanz
Yahoo/Zacks.com
Pfizer
FDA
advisory panels
Xeljanz
ulcerative colitis
Flag link:
FDA advisory group rejects Pacira’s pitch for expanded use of pain drug
FDA advisory group rejects Pacira’s pitch for expanded use of pain drug
Endpoints
FDA
advisory panels
Pacira
pain block
anesthesia
Flag link:
Aradigm crashes after FDA panel votes down antibiotic
Aradigm crashes after FDA panel votes down antibiotic
Fierce Biotech
Aradigm
FDA
advisory panels
antibiotics
Linhaliq
Flag link:
Why an FDA Panel Shot Down Intrinsic's Spinal Implant
Why an FDA Panel Shot Down Intrinsic's Spinal Implant
Medical Devices and Diagnostics Industry
FDA
advisory panels
devices
Intrinsic Therapeutics
spinal implants
Barracaid
Flag link:

Pages